Biolinerx Ltd.-Spons ADRBLRX

13F holders, Q2 2026 (June 30)
14holders +1
4new positions
3sold out
2famous investors
$3.12avg. 13F price*

At the end of Q2 2026, 14 institutions reported holding Biolinerx Ltd.-Spons ADR (BLRX) in their 13F filings, up 1 from Q1 2026. 4 opened new positions and 3 sold out. The largest holders were Susquehanna International Group, LLP ($96K), Renaissance Technologies ($48K) and Citadel Advisors ($46K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Biolinerx Ltd.-Spons ADR
CUSIP
09071M304
Latest filing quarter
Q2 2026

History

Number of 13F holders

05101520 Q4 2024: 1Q4 2024Q1 2025: 12Q1 2025Q2 2025: 17Q2 2025Q3 2025: 14Q3 2025Q4 2025: 14Q4 2025Q1 2026: 13Q1 2026Q2 2026: 14Q2 2026

Total Exit/New Position Q1 2026 → Q2 2026

InstitutionsTotal Value
New Positions4$190K
Exits3$26K

All 13F filers, Q1 2026 → Q2 2026: 61,504 shares bought and 14,533 shares sold, net +46,971 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 14 holders

Susquehanna International Group, LLP 0.00% New 30,911 $96K
Renaissance Technologies 0.00% New 15,412 $48K
Citadel Advisors 0.00% New 14,796 $46K
Rhumbline Advisers 0.00% Add +5.3% 2,478 $8K
Wells Fargo & Company 0.00% Add +14.3% 2,000 $6K
BNP Paribas Financial Markets 0.00% Reduce -72.2% 500 $2K
Banque Cantonale Vaudoise 0.00% No change 1 $1K
Nemes Rush Group LLC 0.00% No change 250 $780
UBS Group AG 0.00% Reduce -80.9% 101 $315
NewEdge Advisors, LLC 0.00% Reduce -23.4% 82 $256
Osaic Holdings, Inc. 0.00% No change 26 $81
SBI Securities Co., Ltd. 0.00% New 10 $31
Danske Bank A/S 0.00% No change 2 $6
Citigroup Inc. 0.00% Reduce -99.9% 1 $3

"% of holder's portfolio" is BLRX's weight in each manager's 13F, not the share of Biolinerx Ltd.-Spons ADR the manager owns.